Treatment with rituximab can lead to meaningful improvements for some people with neurosarcoidosis affecting the brain and/or spinal cord — particularly those with hard-to-treat disease and involvement limited to some […] The post Rituximab treatment may help some neurosarcoidosis patients appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Phase III clinical trials are a pivotal milestone in the journey of developing new treatments for PTSD (Post-Traumatic Stress Disorder). These trials not only confirm the efficacy and safety of potential therapies but also lay the groundwork for regulatory approval and widespread clinical use. In this blog, we’ll dive into what Phase III trials entail, … Understanding Phase III Trials for PTSD: What Are the Next Steps? Read More »| Princeton Medical Institute